PRECLINICAL PHARMACOLOGY OF A NEW SEROTONERGIC RECEPTOR ANTAGONIST, LY281067

被引：0
|
作者：
COHEN, ML
FULLER, RW
KURZ, KD
PARLI, CJ
MASON, NR
MEYERS, DB
SMALLWOOD, JK
TOOMEY, RE
机构：
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 1988年 / 244卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：106 / 112
页数：7
相关论文
共 50 条
  • [41] The In Vitro Pharmacology of LY IGlar (LY2963016): A New Insulin Glargine Product
    Owens, Rebecca A.
    Kahl, Steven D.
    Ruan, Xiaoping
    Zhang, Chen
    Farmen, Mark W.
    Moyers, Julie S.
    Michael, M. Dodson
    DIABETES, 2015, 64 : A265 - A265
  • [42] Clinical Pharmacology of Bosentan, a Dual Endothelin Receptor Antagonist
    Jasper Dingemanse
    Paul L. M. van Giersbergen
    Clinical Pharmacokinetics, 2004, 43 : 1089 - 1115
  • [43] Clinical pharmacology of bosentan, a dual endothelin receptor antagonist
    Dingemanse, J
    van Giersbergen, PLM
    CLINICAL PHARMACOKINETICS, 2004, 43 (15) : 1089 - 1115
  • [44] MCI-9042, A NEW ANTIPLATELET AGENT IS A SELECTIVE S2-SEROTONERGIC RECEPTOR ANTAGONIST
    HARA, H
    OSAKABE, M
    KITAJIMA, A
    TAMAO, Y
    KIKUMOTO, R
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (04) : 415 - 420
  • [45] PRECLINICAL PHARMACOLOGY OF CELIPROLOL - A CARDIOSELECTIVE BETA-ADRENERGIC ANTAGONIST AND MILD VASODILATOR
    PERRONE, MH
    BARRETT, JA
    AMERICAN HEART JOURNAL, 1991, 121 (02) : 677 - 683
  • [46] Preclinical pharmacology of fiduxosin, a novel α1-adrenoceptor antagonist with uroselective properties
    Hancock, AA
    Buckner, SA
    Brune, ME
    Esbenshade, TA
    Ireland, LM
    Katwala, S
    Milicic, I
    Meyer, MD
    Kerwin, JF
    Williams, M
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (02): : 478 - 486
  • [47] Preclinical pharmacology, metabolic stability, pharmacokinetics and toxicology of the peptidic kinin B1 receptor antagonist R-954
    Gobeil, Fernand, Jr.
    Sirois, Pierre
    Regoli, Domenico
    PEPTIDES, 2014, 52 : 82 - 89
  • [48] Behavioural pharmacology of the α5-GABAA receptor antagonist S44819: Enhancement and remediation of cognitive performance in preclinical models
    Gacsalyi, Istvan
    Moricz, Krisztina
    Gigler, Gabor
    Wellmann, Janos
    Nagy, Katalin
    Ling, Istvan
    Barkoczy, Jozsef
    Haller, Jozsef
    Lambert, Jeremy J.
    Szenasi, Gabor
    Spedding, Michael
    Antoni, Ferenc A.
    NEUROPHARMACOLOGY, 2017, 125 : 30 - 38
  • [49] Phenotype pharmacology as a new dimension of receptor pharmacology
    Muramatsu, Ikunobu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 2P - 2P
  • [50] The clinical pharmacology profile of the new antiepileptic drug perampanel: A novel noncompetitive AMPA receptor antagonist
    Patsalos, Philip N.
    EPILEPSIA, 2015, 56 (01) : 12 - 27
12345